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Abstract 
Apoptosis  seems  to  be  involved  in  irnmunosenescence  associated  with  aging.  Moreover,  in  lymphocytes (PBL) of  patients  with 
Akheimer's disease, an increased susceptibirity to the apoprotic pathway has been described possibly due  to impaired protection of  oxidative 
stress. Accordingly. it seemed to be of particular interest to investigate the contribution of normal aging to the susceptibility from human 
lymphocytes 20  programmed cell death.  We coiild  show that PBL from elderly individuals (>60 years) accumuIate apoptosing cells to a 
significant higher extent in spontaneous and activation-induced cell death compared to younger controls (<35 years).  Treatment with the 
oxidative Stressor 2-deoxy-D-ribose or with agonistic-CD95-antibody  pronounced this effect even more implicating a higher sensitivity to 
reactive oxygen species and a higher functionril CD95 expression, respectively.  In addition, expression of the activation markerc HLA-DR 
and CD95 was significantly increased in CD3 "-cells of aged subjects,  while expression of CD25 did not seem to be affected by  age. 
Expression of Bcl-2 was increased in aging and comlated with the number of  apoptotic cells. 
Kqwordv. &in&  Apoptosis: 1,yrnphocytes; Oxidativc stress; dctivation markers; Bcl-2 
Programmed cell death (PCD) or apoptosis is of partic- 
ular interest in aging, as it is thought Xo  play an irnportant 
role in various age-related degenerative diseases. Apoptosis 
of white bIood cells could be one reason for the decrease of 
the  total  number  of  leukocytes  and  the  decrease  of  the 
immune response with aging related Zo  Cancer, infections, 
and autoirnmune disorders [3].  Several changes in lympho- 
cytes have been observed related to aging: diminished syn- 
thesis of gro~h  and survive  factos 146,511,  impaired in- 
tracellular  calcium  regulation  [18],  different  surface 
malecule expression 1431,  and defects of signal transdi~ction 
[36]. Some of these pathological  changes are additionally 
altered in patients witl~  Alzheimer's  disease (AD), but are 
not  present  in  vascular dementia  [13-15,171.  In  order to 
differentiate common and  divergent mechanisms of an en- 
hanced susceptibility of lymphocytes to apoptosis in aging 
and  sporadic  AD, we  investigated  in  detail the molecular 
basis of enhanced apoptosis in aged human lymphocytes. 
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Oxidative  Stress increases  with  aging and  ltads to en- 
hanced cellular damage (e.g. Iipidperoxidation, protein ox- 
idation, DNA damage (for review see ref. [IO]).  In addition, 
reactive axygen species (ROS) can trigger cells to undergo 
pragrammed cell death and can act as second rnessenger by 
influencing transcription factors like NF-KB and AP-I. In- 
creased oxidative stress and decreased ability to cope with 
ROS could ampliQ apoptotic cell death in aging lympho- 
cytes. BcI-2 acts in an antioxidative and antiapoptotic way 
and can interfcre with the apoptotic pathway  17,471. 
One oF  the best known and characterized surface recep- 
tors related to PCD in lymphocytes is ApollFas (CD95),  a 
rnernber of the himor necrosis  factor (W)  superfamily. 
Stimulation of this receptor by binding to itc physioiogical 
ligand  (Fas-L) or an agonistic  anti-Fas  antibody  leads to 
apoptosis via a distinct patlqway 1261. In addition, activated 
lymphocytes  express  the  a-chain  of  the  ILZreceptor 
(CD25) and the MHC classd1 related molecuIe HLA-DR. 
Lymphocytes bearing these surface motecules or activation 
markers  141  show  enhanced  sensitivity  to apoptosis upon 
stimulation of these receptors. Accumulation of chronically 
activated lyrnphocytes seems to be one reason for Ihe higher 
susceptibility to apoptotic celt death probably  leading 10  a 
lowered  Ieukocyte  number  in  aged  individuals.  In  the present study, we evaluated the basal, spontaneous, activa-
tion-, and agent-induced apoptosis and ROS of native and
activated peripheral human lymphocytes. In addition, basal
expression of activation markers (CD25, CD95, and HLA-
DR) and Bcl-2 was determined.
2. Materials and Methods
2.1. Subjects
Blood samples were taken from n 5 85 healthy subjects
(55 women and 30 men) between 15 and 93 years. There
were 20 women and 12 men in the aged group (n 5 32; aged
over 60 years, mean age 73.8 6 8.3 years) and 25 women
and 9 men in the group of young controls (n 5 34; age
under 35 years, mean age 26.4 6 5.1 years). The remainders
were part of the intermediate ages shown in Figs. 3, 4, and
6. Subjects with psychiatric and neurodegenerative disor-
ders or acute infections were excluded. In addition, subjects
with pathological distribution of lymphocyte subpopula-
tions in ﬂow-cytometric analysis according to the Senieur
protocol [25] were rejected from the study. Most of the
elderly patients were taking drugs against cardiovascular
disorders. None of the patients received psychotropic med-
ication, drugs with known effects on the immune system, or
antioxidative agents.
2.2. Cells
Peripheral blood lymphocytes (PBL) were prepared from
healthy donors by separating on Ficoll (Biochrom KG,
Berlin, Germany) as previously described [16]. Cells were
investigated directly (native cells/PBMC) or after short-
term culture (activated cells or so called lymphoblasts) as
indicated. In concordance with other studies [1,48], the T
cell subsets CD4 and CD8 did not differ signiﬁcantly with
aging, as measured in wholeblood by FACS analysis. For
short-term culture, cells were seeded at a density of 0.5 3
10
6/ml in complete medium (RPMI-1640 supplemented
with 10% FCS, penicillin (100 U/ml), and streptomycin
(100 mg/ml; all GibcoBRL, Karlsruhe, Germany) supple-
mented with 5 mg/ml PHA-L (Sigma, Deisenhofen, Germa-
ny). After 48 h of incubation at 37°C and 5% CO2, cells
were washed once in PBS (Gibco BRL), seeded in complete
medium containing 50 U/ml of human recombinant IL-2
(Boehringer Mannheim), and incubated for 72 h to predis-
pose to apoptosis according to the method of Zheng et al.
[53]. Activated lymphocytes consisted to nearly 100% of
CD3
1 cells and expressed CD95 to over 96% as determined
in FACS analysis.
2.3. Induction of apoptosis
Cell death was induced with the following stimuli for
24 h: 10
27 M dexamethasone, 10 mM 2-deoxy-D-ribose,
100 nM staurosporine (all purchased from Sigma) or 0.4
ng/ml agonistic CD95-antibody (clone 2R2, Boehringer
Mannheim, Mannheim, Germany). Incubation of cells over
24 h with medium alone and in the absence of an additional
stimulus is termed “spontaneous in vitro apoptosis.” Spon-
taneous in vitro apoptosis is deﬁned by the cell death of
primary adult cells that occurs after removing them from
their natural environment and culturing them under in vitro
conditions. Withdrawal of the growth factor IL-2 leads
lymphoblasts into the so-called activation-induced cell
death (AICD).
2.4. Assays of apoptotic cell death
For analyzing the sub-G1 DNA content, which is deﬁned
as percent apoptotic cells, lymphocytes were harvested by
centrifugation at various time points and the pellets resus-
pended in lysis buffer (0.1% sodium citrate and 0.1% Triton
X-100) containing 50 mg/ml of propidium iodide (all
Sigma) ([29]). Samples were stored at 4°C for 1–2 h before
ﬂow cytometry analysis (FACSCalibur) using CELLQUEST
software (both Becton Dickinson).
2.5. Determination of oxidative stress
The production of ROS was detected by ﬂow cytometry
using dihydrorhodamine 123 (DHR; Molecular Probes) as
described elsewhere [35,38]. Lymphocytes (1.25 3 10
5)
were suspended in 1 ml HBSS, and DHR was added to a
ﬁnal concentration of 10 mM and incubated for 15 min at
37°C. Then, the conversion of DHR to its ﬂuorescent de-
rivative rhodamine 123 was detected. Control samples con-
taining no stimulus were run in parallel, and all aliquots
were stored on ice before analysis (“baseline”). The mean
ﬂuorescence intensity (MFI) in FL1 was calculated by de-
termining the mean channel number (MCN) of the peak.
This MCN value was converted to a linear value for com-
parative purposes by calculating the antilog of x 5 sample
mean channel/(total number of channels/number of log de-
cades) 5 sample mean channel/(1024/4) 5 sample mean
channel/256. All data presented are expressed as D MFI,
representing the increase over baseline.
2.6. Examination of surface-expressed receptors
Determination of CD3, CD19, CD4, CD8, HLA-DR,
CD56 1 CD16, CD95, and CD25 was performed with an
aliquot of the heparinized blood sample with the SimulSet
staining kit (Becton Dickinson) according to the manufac-
turer’s manual. Samples were assayed with FACSCalibur
using SIMULSET software (all Becton Dickinson).
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The content of Bcl-2 was determined from peripheral
lymphocytes (1 3 10
6 cells) with an ELISA assay (Onco-
gene, USA) according to the manufacturer’s manual.
2.8. Statistics
Statistical analysis was performed by Student’s paired/
unpaired t-test or correlation calculations (PRISM 2.01;
GraphPad Software, San Diego, CA, USA). All data pre-
sented are means 6 SEM.
3. Results
3.1. Basal and spontaneous apoptosis are increased in
lymphocytes of elderly subjects
Using PI staining, we quantiﬁed sub-G1-DNA content in
lymphocytes from healthy elderly and young controls. Fig.
1 shows the histogram plots of PI-stained lymphocytes of
two representative subjects. Student’s t-test revealed that
the percentage of basal apoptotic nuclei in freshly isolated
lymphocytes was signiﬁcantly elevated in aged subjects
compared to young controls (means 6 SEM: old, 1.35 6
0.20% versus young, 0.84 6 0.11%; *, P , 0.05; Fig. 2a).
In addition, we found a signiﬁcantly higher content of cells
undergoing spontaneous in vitro apoptosis after 24 h in the
group of old subjects in relation to young ones (Fig. 2b; **,
P , 0.01; old, 8.06 6 0.85%, median 5.90%; young, 5.52 6
0.43%, median 4.60%). Subtracting the background of basal
cell death still revealed signiﬁcantly higher levels of apo-
ptotic cells in lymphocytes from aged controls (D increase
over baseline: old, 6.56 6 0.86% versus young, 4.33 6
0.42%; *, P 5 0.014; Fig. 2c). Moreover, when all inves-
tigated subjects were pooled for regression analysis, in-
creasing age was correlated with percentage of apoptotic
cells by regression analysis. Spontaneous apoptosis after
24 h increased 2.1-fold (slope 5 0.061 6 0.02) between 15
and 93 years of age [Fig. 3, dotted line (- - -)]. There was a
signiﬁcant (***, P , 0.001, n 5 85) correlation between
age and the portion of apoptotic cells. To ascertain that these
alterations in apoptotic cell death were not linked to alter-
ations in the distribution of PBMC subpopulations, the same
experiments were performed with activated lymphocytes
consisting to over 95% of CD3
1 cells. Lymphocytes, which
are undergoing proliferation, can be triggered to pro-
grammed cell death by withdrawal of IL-2. IL-2 is the most
critical determinant in this process [23]. Activated lympho-
cytes have been shown to be more sensitive to apoptosis
than nontreated native cells. Basal apoptotic levels of acti-
vated T cells correlated signiﬁcantly with the donor age
(*, P , 0.05, n 5 52; Fig. 4; young, 9.99 6 1.05%, median
9.87% versus old, 13.29 6 1.04%, median 12.17%). In
addition, spontaneous in vitro apoptosis after 24 h (under
these conditions also called AICD: activation-induced cell
death, that is triggered by IL-2 treatment followed by with-
drawal) did as well signiﬁcantly correlate with age (*, P ,
0.05, n 5 45; Fig. 4; young, 16.22 6 1.29%, median
15.23% versus old, 19.58 6 1.45%, median 19.15%).
3.2. Increased basal levels of ROS in aging
The oxidative-sensitive ﬂuorescent dye DHR 123 was
used to detect presence of ROS in human lymphocytes.
Fig. 1. Histogram plots of propidiume-iodide stained and lysed PBMC from each an old (upper level) and a young (lower level) individual. Percentage of
sub-G1-DNA-content (% apoptotic cells) under different conditions is indicated. First column shows basal apoptotic levels of freshly isolated PBMC, the
second displays the spontaneous in vitro apoptosis after 24 h in culture, and the last two columns exhibit dRib- and CD95-induced apoptosis after 24 h.
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accumulate signiﬁcantly in aged human lymphocytes (Fig.
5; *, P , 0.05; n 5 26–27).
3.3. PBMC from aged donors are more vulnerable to
induction of apoptosis by oxidative stress
Oxidative stress was induced with 2-deoxy-D-ribose
(dRib) [6]. Cells were incubated for 24 h at 37°C, harvested,
and propidium iodide stained and analyzed by ﬂow cytom-
etry. In the presence of 10 mM dRib, the sub G1-DNA
content was elevated in both groups, but PBMC of elderly
subjects react signiﬁcantly more sensitive to this apoptotic
Fig. 2. (a) Basal levels of apoptotic nuclei in freshly isolated PBMC. Apoptosis was determined by propidium iodide staining as described in Section 2. Cells
derived from aged humans (over 60 years old) display signiﬁcantly more basal apoptotic nuclei (1.35 6 0.196%, n 5 34) than younger controls (up to 35
years old; 0.840 6 0.113%; n 5 32; *, P , 0.05, Student’s t-test). (b) Spontaneous apoptosis in PBMC of young and old humans: cells were cultured for
24 h in the absence of stimuli. In aging, signiﬁcantly more apoptotic cells accumulate under this condition. PBMC from old subjects displayed 8.06 6 0.85%
apoptotic cells while young subjects showed only 5.52 6 0.43% apoptotic nuclei; **, P , 0.01. (c) The age-related difference in spontaneous apoptosis is
still present after subtraction of the individual basal background (young, 4.33 6 0.42% versus old, 6.56 6 0.86; *, P 5 0.014).
Fig. 3. Spontaneous and CD95-induced apoptosis in PBMC after 24 h
incubation. Lymphocyte apoptosis correlates with increasing age. PBL
from subjects ranging from 17 to 82 years of age were cultured 24 h in vitro
and spontaneous apoptosis (E) was determined by ﬂow cytometry analysis.
% Apoptotic cells was correlated with donor age (r 5 0.34; ***, P ,
0.001, n 5 85). The percent increase per year is 0.06 6 0.03%. l
symbolize apoptosis of cells cultured for 24 h with an agonistic CD95-
antibody. In addition, correlation with age is also highly signiﬁcant (r 5
0.50; ***, P , 0.001, n 5 46). CD95-induced apoptosis increases even
more with age than the spontaneous in vitro apoptosis does (slopes of the
linear regression analysis: 0.122 6 0.04; 0.061 6 0.02, respectively).
Fig. 4. Basal apoptotic levels and activation-induced cell death (AICD) of
activated lymphoblasts correlate signiﬁcantly with the age of the donor. E
show basal apoptotic levels after lymphocyte activation as described in
Section 2. Correlation with subjects’ age is signiﬁcant (*, P , 0.02; n 5
52). F display AICD of activated lymphoblasts after 24 h withdrawal of
IL-2 (*, P , 0.03; n 5 45).
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taneous apoptosis, a signiﬁcant increase of vulnerability to
ROS-induced apoptosis was determined (Fig. 6: correlation
*, P , 0.05 and Fig. 7a: old, 7.92 6 1.8% versus young,
3.0 6 1.2%; *, P , 0.05), indicating an age-related impair-
ment to cope with oxidative stress. In addition, higher con-
centrations of 2-deoxy-D-ribose (50 mM) yielded in a higher
percentage of apoptotic cells, which was not any different
between young and aged lymphocytes (old, 7.22 6 1.20
versus young, 6.85 6 1.45; n 5 37 per group; P 5 0.42).
Moreover, PBMC derived from aged volunteers showed
signiﬁcantly increased levels of ROS, as determined by
DHR123 ﬂuorescence, after dRib treatment compared to
young subjects (Fig. 7b; *, P , 0.05; n 5 23–24).
3.4. Functional CD95 expression is higher in lymphocytes
of elderly subjects
Incubation for 24 h with an agonistic monoclonal anti-
CD95 antibody that acts like a Fas-L, showed signiﬁcant
changes in the induction of apoptosis between cells from
young and old done on native cells (young, 6.19 6 0.26%,
median 5.74%; versus old, 11.05 6 1.78%, median 9.11%;
***, P # 0.001). Apoptotic cells correlated signiﬁcantly
with donor age after incubation with a CD95 antibody (***,
P , 0.001; Fig. 3, black line). However, in young donors,
the number of apoptotic cells is not altered after CD95
treatment compared to spontaneous apoptosis (paired t-test
is not signiﬁcant). In contrast, PBMC from aged donors are
far more sensitive to apoptosis with agonistic CD95 anti-
body (paired t-test gave: ***, P , 0.001).
By subtracting the spontaneous apoptosis in each subject,
the CD95-induced apoptosis is determined that increases
signiﬁcantly with aging (Fig. 6).
3.5. Elevated expression of activation markers in aging
In order to explore the mechanism for the increased
susceptibility to apoptosis in PBMC from aged donors, we
Fig. 5. Basal levels of ROS in human peripheral lymphocytes. Signiﬁcantly
higher levels could be determined in aging (old, 1.310 6 0.025; n 5 27;
versus young, 1.239 6 0.021; n 5 26; *, P , 0.05).
Fig. 6. Spontaneous in vitro apoptosis was subtracted from CD95- and
dRib-induced apoptosis resulting in the percentage of apoptosis induced by
the agent. This so-called induced apoptosis over control was correlated
with age of subjects. * Represent dRib-induced apoptosis; L symbolize
CD95-induced apoptosis.
Fig. 7. (a) Induced apoptosis over control after 24 h by dRib (10 mM) and
staurosporine (100 nM) in groups of young and old subjects (dRib: young,
3.00 6 1.19 versus old, 7.92 6 1.74, n 5 11; *, P , 0.05; staurosporine:
23.71 6 6.33 versus 27.65 6 5.63; NS; n 5 11, respectively). (b) ROS
levels in PBMC cultured for 16 h with dRib and staurosporine. Incubation
with the oxidative stressor dRib leads to an age-related increase in
DHR123 ﬂuorescence (D increase over baseline; old, 0.276 6 0.037 versus
young, 0.191 6 0.018; n 5 24; *, P , 0.05). Treatment with the potent
apoptotic agent staurosporine generates increased levels of ROS without
any age-related differences (old, 0.277 6 0.023 versus young, 0.259 6
0.022, n 5 16).
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CD95 (Apo, Fas), and CD25 (IL-2-receptor). Quantitation
of T lymphocytes expressing HLA-DR, CD95, and CD25
(IL2-Ra) was performed by direct immunoﬂuorescence in
wholeblood followed by FACS analysis (Fig. 8). CD3
1 T
cells from young donors (up to 35 years) showed a signif-
icantly (***, P , 0.0001) smaller portion of HLA-DR-
positive cells (5.9 6 0.4%) than CD3
1-T lymphocytes from
aged subjects (10.8 6 1.0%). CD3
1 cells from young do-
nors expressed signiﬁcantly less CD95 receptors than el-
derly subjects over the age of 60 years (young, 34.2 6 2.3%
versus old, 46.4 6 6%). No signiﬁcant changes with age
concerning the expression of CD25 could be detected
(young, 13.3. 6 0.7% versus old, 14.8 6 1.3%).
The portion of cells displaying CD95 correlates, as ex-
pected, signiﬁcantly with the percentage of CD95-agonistic
antibody-induced apoptosis (data not shown), conﬁrming
the age-related increase in CD95-induced cell death.
The more the peripheral lymphocytes express CD95 and
CD25 at basal levels, the higher is the percentage of cells
undergoing apoptosis initiated by glutathione depletion (10
mM and 50 mM dRib) as shown by correlation (Fig. 9),
indicating that these lymphocytes are more susceptible to
oxidative stress.
3.6. Apoptosis induced by staurosporine does not
correlate with aging
To examine whether the age-related apoptosis is associ-
ated with oxidative stress and/or higher expression of acti-
vation receptors, we also induced PCD in PBMC by stau-
rosporine. Incubation of PBMC with 100 nM staurosporine
showed a dramatic increase in the percentage of apoptotic
cells compared with the untreated controls undergoing
spontaneous apoptosis (***, P , 0.001). However, no sig-
niﬁcant effect could be determined related to aging (Fig.
7a). Staurosporine induces apoptosis independently from
the donor’s age. Moreover, we investigated the content of
ROS in staurosporine-induced apoptosis. The elevated lev-
els of ROS compared to basal levels are in line with the
assumption that staurosporine-induced cell death is down-
stream mediated by ROS, but mainly upstream by caspases
[21] in contrast to dRib where ROS act upstream [20]. No
age-effect was found for the staurosporine-induced eleva-
tion of ROS (Fig. 7b).
3.7. Elevated levels of Bcl-2 in lymphocytes from
aged humans
Overexpression of Bcl-2 counteracts apoptotic processes
[7] probably by activating anti-oxidative mechanisms [47].
To investigate the link between apoptosis and oxidative
stress in peripheral human lymphocytes, we determined the
basal content of Bcl-2 in freshly isolated PBMC by ELISA.
The amount of Bcl-2 increases slightly but not signiﬁcantly
in aging (Fig. 10, inset). Moreover, there was a positive
correlation between the content of Bcl-2 and the percentage
of basal apoptotic cells (Fig. 10; *, P , 0.05; n 5 18). In
Fig. 8. Determination of surface expressed activation markers of CD3
1-
lymphocytes from young and old genders (n 5 32–34). T cells from young
donors displayed a signiﬁcantly (***, P , 0.0001) smaller portion of
HLA-DR-positive cells (5.9 6 0.4%) than T lymphocytes from older
subjects (10.8 6 1.0%). CD3
1 cells from young donors expressed signif-
icantly less CD95 receptors than elderly subjects (young, 34.2 6 2.3%
versus old, 46.4 6 2.6%). No signiﬁcant changes with age concerning the
expression of CD25 could be determined (young, 13.3. 6 0.7% versus old,
14.8 6 1.3%).
Fig. 9. Correlation of dRib-induced (50 mM) apoptosis and basal expression of activation markers. Correlation with (a) HLA-DR (NS, P 5 0.07, n 5 33);
(b) with CD95 (***, P , 0.0001; n 5 25); and (c) with CD25 (**, P , 0.01, n 5 41).
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Bcl-2 correlates signiﬁcantly with donor age (*, P , 0.05),
in activated cells from younger donors more Bcl-2 could be
detected than in activated cells derived from aged subjects
(old, 32.71 6 4.83 U Bcl-2/mg protein versus young,
61.07 6 15.85 U Bcl-2/mg protein, n 5 7 per group, P 5
0.056), indicating an important role of Bcl-2 in lymphocyte
activation.
4. Discussion
Previous results of our group reported an increased con-
tent of basal and dRib-induced apoptotic cells in PBMC
from patients with Alzheimer’s disease relative to age-
matched controls [13,40]. This effect is probably not related
to the physiological process of immunosenescence. In ad-
dition, apoptosis is a hallmark in brains derived from Alz-
heimer’s patients, possibly associated with states of in-
creased oxidative stress [8,45,49,52]. Similar alterations
could also be detected in peripheral cells of AD patients
[27,31]. In order to understand the speciﬁc contribution of
AD to the enhanced susceptibility of lymphocytes to apo-
ptosis, it is of particular importance to know ﬁrst the role of
normal aging without dementia. In this study, we explored
therefore the age-related apoptotic behavior of peripheral
human lymphocytes and the role of oxidative stress.
In the present study, we showed age-related differences
in the vulnerability of cell death. PBMC and activated
CD3
1 lymphoblasts from elderly subjects have an enhanced
susceptibility to spontaneous and activation-induced in vitro
apoptosis. We found some overlap of apoptotic features for
spontaneous or activation-induced in vitro apoptosis be-
tween young and old controls. Hereby, few old control
subjects showed low levels of apoptotic cells, whereas oth-
ers exhibited very high apoptotic features. We can not
completely rule out that these ﬁndings are confounded by
some case of subclinical Alzheimer’s disease. At the time
point of collecting the blood samples, none of our donors
showed any clinical signs of dementia. In addition, a similar
increase and distribution of apoptotic features have been
detected in lymphocytes of old mice when compared to
young ones (unpublished ﬁndings). Thus, our results very
likely reﬂect differences of aging. Basal levels of apoptotic
nuclei in freshly isolated PBMC are signiﬁcantly elevated in
the group of aged donors compared to younger ones. In
addition, basal levels of ROS are similarly increased in
aging. This enhanced vulnerability is probably not related to
a decline in IL-2 production [32] but must be correlated
with an increased basal expression of activation markers
(e.g. CD95, CD25, CD69, HLA-DR) and higher levels of
ROS. Usually, apoptotic cells are eliminated quite fast after
generation. A higher percentage of basal apoptotic levels in
aged human PBMC could indicate an impaired phagocyto-
sis of these cells in the aging organism.
The basal apoptotic content has been measured after the
isolation procedure of PMBC by density centrifugation. We
can not exclude that during the preparation of PBMC within
2 h cells were damaged or were triggered to undergo cell
death. However, another study using lysed whole blood
technique found similar results in regard to signiﬁcantly
elevated basal apoptosis in lymphocytes from old humans
compared to young controls, but even about 5-fold higher
basal apoptotic levels compared to our study [34]. There-
fore, our isolation procedure seems to be rather gentle and
the detected basal apoptosis may at least partly reﬂect al-
ready existing apoptotic cells.
The content of Bcl-2 raises slightly in peripheral cells
with aging. Moreover, we and others could show that rest-
ing peripheral blood cells do not express large amounts of
Bcl-2 at all, but the content of Bcl-2 increases signiﬁcantly
after activation with PHA-L and IL-2 [37]. Basal amounts
of Bcl-2 correlate with the content of basal apoptotic cells in
aging. Since Bcl-2 is a physiological apoptosis inhibitor, it
could be possible that cells prone to undergo apoptosis
express higher amounts of Bcl-2 as a defending mechanism.
Therefore, it appears not to be surprising that apoptotic cells
display more Bcl-2 at basal levels. Activated lymphoblasts
displayed the more Bcl-2 the younger the donor was. These
data implicate a strong correlation between lymphocyte’s
functionality concerning activation and the donor age. It
seems that the decreased amount of Bcl-2 in activated lym-
phoblasts in aging might be one factor contributing to im-
munosenescence.
This higher susceptibility to apoptosis in aging might be
due to an enhanced production and/or not satisfactory elim-
ination of reactive oxygen species in aging, thereby leading
to apoptosis. Mitochondria are the major site, where free
oxygen radicals are produced. In aging, mutations accumu-
late in mtDNA, due to its vicinity to radical formation [28].
The mutant mtDNA leads to mitochondria with impaired
respiratory function [2]. In addition, ROS act as intracellular
Fig. 10. Basal expression of Bcl-2 increases with aging (inset) in human
PBMC. Peripheral cells of young subjects displayed 19.6 6 5.7 U Bcl-
2/mg protein, PBMC of aged volunteers expressed 25.8 6 5.7 U Bcl-2/mg
(n 5 9). Content of Bcl-2 correlates signiﬁcantly (*, P , 0.03; n 5 18)
with basal percentage of apoptotic cells in freshly isolated PMBC from
young and old donors.
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apoptosis [5] by interacting with redox-sensitive transcrip-
tion factors like NFkB.
Reduced glutathione (GSH) is an important antioxidant
factor in the cell. Depletion of intracellular GSH inhibits T
cell function [12]. Recently, it could be shown that the
levels of GSH decrease in aging in human lymphocytes
[50]. The sugar 2-deoxy-D-ribose provokes oxidative stress
in cells probably by depleting the intracellular levels of
reduced glutathione [20] and it is involved in the formation
of free radicals [6], as it signiﬁcantly elevates the level of
ROS in lymphocytes compared to untreated controls [24].
The apoptotic process initiated with dRib can be blocked
with N-acetyl-L-cysteine (NAC) a potent radical scavenger
[39]. Therefore dRib is a useful tool to simulate oxidative
stress in human lymphocytes as shown by [13]. We found
that with increasing donor age, peripheral blood cells can
cope worse with oxidative stress induced by incubation with
10 mM dRib. Compared to spontaneous apoptosis, dRib-
induced apoptosis increases more with age. A possible
cause for this ﬁnding could be the decreased levels of GSH
found in aging lymphocytes [50]. It can be concluded that
the less GSH a cell contains, the higher is the susceptibility
to apoptosis induced by 10 mM dRib. Moreover, dRib
induces signiﬁcantly higher levels of ROS in PBMC derived
from aged donors compared to younger ones. However, as
the increase of ROS in aged lymphocytes induced by dRib
is less than the increase of apoptosis, other parameters might
be additionally relevant. Under these conditions, only little
(,1%) necrosis was found as determined with another
staining method using 7-aminoactinomycin D [41]. Higher
dRib concentrations (.50 mM dRib) were necessary to
induce higher levels of necrosis (unpublished data, see also
ref. 14). The content of apoptotic cells induced by 50 mM
dRib did not correlate with age. Interestingly, the percent-
age of 50 mM dRib induced apoptotic cells correlates sig-
niﬁcantly with the content of lymphocytes basally express-
ing the activation markers CD25, CD95, and HLA-DR.
Apoptotic cells induced with a lower concentration of dRib
(10 mM) did correlate as well with the expression of CD25.
Correlation of 10 mM dRib with CD95 and HLA-DR could
not be done as their expression is age-related as well and is
therefore linearly related. It seems that dRib leads activated
cells more into apoptosis than resting cells, maybe by a
different mechanism, providing a powerful tool to explore
lymphocyte apoptosis.
It is important to note that the age-related increased
susceptibility of PBMC to dRib was not found for stauro-
sporine. Staurosporine-induced elevation of ROS and stau-
rosporine-induced apoptosis were not different in young or
aged lymphocytes. Staurosporine induced comparable lev-
els of ROS as dRib did. However, due to the involvement of
caspases in staurosporine-induced death signaling upstream
of ROS [21], higher levels of apoptotic cells were reached
in young as well as in old subjects when compared to
dRib-induced apoptosis. Staurosporine-mediated ROS serve
rather as a second messenger [5] and GSH is primarily not
affected. Obviously, only certain speciﬁc become mecha-
nisms disturbed in aged lymphocytes.
In concordance to other groups, we found that the basal
expression of functional CD95 increases with age [22,32].
We determined expression of CD95 surface molecule as
well as its function with an agonistic antibody leading to
apoptosis-speciﬁc DNA fragmentation. T lymphocytes from
young donors expressed about 12% CD95 less compared to
elderly individuals, while only 0.3% of PBMC of young
subjects displayed apoptotic morphology after 24 h of in-
cubation with anti-CD95. In the group of aged genders,
apoptosis could be induced in about 2.3% of the PBMC.
These data implicate that most of the expressed CD95-
molecules on CD3
1 cells are not fully functional, maybe
due to a lack of the FADD-protein (Fas-associated death
domain), since Aggarwal and colleagues could demonstrate
for another receptor of the same death receptor super family
that TNF-a-induced apoptosis in aged human lymphocytes
is associated with an altered expression of the correspond-
ing death domain (TRADD) and death factor (TRAF-2) [1].
In aging, the number of functional CD95 expression raises.
Our data of expression of CD95 of native CD3
1 lympho-
cytes are consistent with the ﬁndings of Phelouzat et al.
[32], who reported that enhanced susceptibility to apoptosis
of T lymphocytes from elderly done is associated with
increased expression of the CD95-receptor. Moreover
Seishima et al. [42] reported that soluble Fas receptor (sFas)
is elevated in serum of aged persons.
Our lab and others have previously provided evidence
that the susceptibility to apoptosis of peripheral cells is
impaired in Alzheimer’s disease: basal levels of apoptotic
PBMC are signiﬁcantly increased in AD compared to age-
matched not demented controls [40], in addition dRib-in-
duced apoptosis is altered [13] while spontaneous apoptosis
is quite not affected indicating a higher vulnerability to
oxidative stress in cells of demented patients. Further,
CD95-induced apoptosis is not altered in AD, indicating
that mechanisms are evident here that do not contribute to
accelerated aging in AD. Moreover, different but not typical
age-related expression of activation markers and members
of the Bcl-2 family has been reported in dementia of the
Alzheimer’s type in brain tissue [11,19,30] and as well in
AD lymphocytes [33,44]. Therefore, it seems that the patho-
logical changes that take place in the brain of AD patients
are not limited to neuronal brain tissue and can be detected
in peripheral cells as well. This study will help to further
explore the mechanisms taking place in AD and whether
they are related to the physiological aging-process.
In conclusion, aging leads to quite speciﬁc changes of the
susceptibility of human lymphocytes to apoptotic cell death.
This knowledge will help to elucidate additional changes
taking place in AD.
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